(2001). Phase I trial of a Plasmodium vivax CS derived synthetic peptide vaccine candidate.
Chicago Style (17th ed.) CitationPhase I Trial of a Plasmodium Vivax CS Derived Synthetic Peptide Vaccine Candidate. 2001.
MLA (8th ed.) CitationPhase I Trial of a Plasmodium Vivax CS Derived Synthetic Peptide Vaccine Candidate. 2001.
Warning: These citations may not always be 100% accurate.